Sierra Oncology Inc (SRRA) Stock News

NASDAQ:SRRA - US82640U4040 - Common Stock

54.99

+0.02 (+0.04%)

Last: 6/30/2022, 8:00:01 PM

54.99

0 (0%)

After Hours: 6/30/2022, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SRRA Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: Benzinga - Mentions: ACAD IBB CO ABBV ...

The Daily Biotech Pulse: Addex Terminates Parkinson's Study, Expanded Use Of Rhythm's Obesity Drug, FDA Approval For AbbVie's Skyrizi In Crohn's Disease

3 years ago - By: Sierra Oncology

Sierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration

3 years ago - By: InvestorPlace - Mentions: GSK NVAX PFE BNTX ...

6 Biotech Stocks to Buy Now Ahead of These June Catalysts

3 years ago - By: InvestorPlace - Mentions: KYMR PTGX KZR JNJ ...

3 Biotech Stocks to Buy Before They Boom

3 years ago - By: Benzinga

Recap: Sierra Oncology Q1 Earnings

3 years ago - By: Sierra Oncology

Momelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual Meeting

3 years ago - By: Sierra Oncology

Sierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual Meeting

3 years ago - By: Sierra Oncology

Sierra Oncology Reports First Quarter 2022 Results

3 years ago - By: Invezz

Late-Stage Biopharmaceutical Sierra Oncology announces acquisition by GSK

3 years ago - By: Sierra Oncology

Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

3 years ago - By: Kahn Swick & Foti, LLC

SIERRA ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sierra Oncology, Inc - SRRA

3 years ago - By: Kuznicki Law PLLC

SIERRA ONCOLOGY INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Sierra Oncology, Inc - SRRA

3 years ago - By: Kahn Swick & Foti, LLC

SIERRA ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sierra Oncology, Inc - SRRA

3 years ago - By: Weiss Law - Mentions: GSK

SHAREHOLDER ALERT: Weiss Law Investigates Sierra Oncology, Inc.

3 years ago - By: InvestorPlace - Mentions: CRTD URBN KLDO HPK

Why Is Creatd (CRTD) Stock Up Today?

3 years ago - By: InvestorPlace - Mentions: KLDO HPK UBER

Dear KLDO Stock Fans, Mark Your Calendars for April 28

3 years ago - By: InvestorPlace - Mentions: GSK ATRS HALO GILD

Why Is Sierra Oncology (SRRA) Stock Up Today?

3 years ago - By: Investor's Business Daily - Mentions: GSK HALO ATRS

Biotech Stock Sierra Soars On GSK Buyout As Halozyme Nabs Antares

3 years ago - By: Halper Sadeh LLP

SRRA Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Sierra Oncology, Inc. Is Fair to Shareholders

3 years ago - By: InvestorPlace - Mentions: ATRS HALO AGRX GSK ...

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

3 years ago - By: Sierra Oncology

GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn

3 years ago - By: Sierra Oncology

Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)